Decreased Anti-DSG3, Not Anti-DSG1 Antibody, After Cessation of Sitagliptin Treatment for Pemphigus Vulgaris

This case report describes the occurrence of a decrease of anti-DSG3, but not anti-DSG1, after cessation of sitagliptin treatment in a patient with pemphigus vulgaris.
Source: JAMA Dermatology - Category: Dermatology Source Type: research